0001441844-12-000002.txt : 20121116
0001441844-12-000002.hdr.sgml : 20121116
20121116135443
ACCESSION NUMBER: 0001441844-12-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121115
FILED AS OF DATE: 20121116
DATE AS OF CHANGE: 20121116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baker Mark Robert
CENTRAL INDEX KEY: 0001331438
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 121211104
MAIL ADDRESS:
STREET 1: 120 STATE STREET
CITY: BROOKLYN
STATE: NY
ZIP: 11201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-11-15
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001331438
Baker Mark Robert
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
CEO
Common Stock
2012-11-15
4
P
0
48833
1.686
A
93672
D
This transaction was executed in multiple trades at prices ranging from $1.620 to $1.710. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Mark R. Baker
2012-11-16